MEK inhibition preferentially suppresses anchorage-independent growth in osteosarcoma cells and decreases tumors in vivo.
Shimizu T, Kimura K, Sugihara E, Yamaguchi-Iwai S, Nobusue H, Sampetrean O, Otsuki Y, Fukuchi Y, Saitoh K, Kato K, Soga T, Muto A, Saya H.
Shimizu T, et al. Among authors: nobusue h.
J Orthop Res. 2021 Dec;39(12):2732-2743. doi: 10.1002/jor.25023. Epub 2021 Mar 26.
J Orthop Res. 2021.
PMID: 33751653
Free article.